Clinical trial
Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful…
NCT00496457 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00496457 |
|---|---|
| Title | Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy |
| Official title | A Double-Blind, Randomized, Multicenter Study With 500 mg QD of TRO19622 Versus Placebo in Patients With Painful Peripheral Diabetic Neuropathy |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Collaborators | Ergomed GmbH Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathy |
| Intervention type | Drug |
| Interventions | Experimental, Placebo comparator |
| Enrollment | 159 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jul 4, 2007 |
| Last update posted | Nov 22, 2016 |
| Countries | Croatia, Germany, Latvia, Poland, Serbia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: